# Strides Pharma Science Ltd (STAR)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1153.2
Day Change: -0.51%
52W High: ₹1231
52W Low: ₹660.05
Market Cap: ₹10,613 Cr

## Valuation
P/E: 20.75
P/B: 3.85
EPS: ₹55.49
Book Value: ₹299.06
Dividend Yield: 0%

## Returns
1Y Return: 24.66%

## Profitability
ROE: 0%
ROCE: 25%
Debt/Equity: 0.66
Revenue Growth: 3.6%
Profit Growth: 129.5%
EBITDA Margin: 18.01%
Operating Margin: 15.51%

## About
Strides Pharma Science Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Strides Pharma Science Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:15.406Z
Price History Updated: 2026-05-18T22:58:25.814Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:25.814Z
Quant Updated: 2026-05-18T22:58:25.814Z
Sentiment Updated: 2026-05-18T22:58:25.814Z
Financials Status: current
Financials Updated: 2026-05-18T10:32:10.312Z
Financials Last Attempt: 2026-05-18T10:32:10.312Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹1196 Cr
Operating Profit: ₹229 Cr (OPM 19%)
Net Profit: ₹844 Cr
Tax: ₹992 Cr

## Annual P&L History
Mar 2016: Rev ₹1196Cr | PAT ₹844Cr | OPM 19%
Mar 2017: Rev ₹2861Cr | PAT ₹95Cr | OPM 13%
Mar 2018: Rev ₹2755Cr | PAT ₹446Cr | OPM 19%

## Balance Sheet (Mar 2016)
Total Assets: ₹2475 Cr
Total Liabilities: ₹2475 Cr
Borrowings: ₹892 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Arun Kumar Pillai B.Com., Founder & Non-Executive Chairperson
- Badree  Komandur, MD & Group CEO
- Vikesh  Kumar, Group CFO
- Manjula  Ramamurthy, Compliance Officer & Company Secretary
- Aditya Arun Kumar, Executive Director of Business Development & Director

---
Source: rupiya.io/stocks/star
Disclaimer: For research and education only. Not investment advice.